Haemonetics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results.
Haemonetics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results.
美國血液技術股價上漲,公司發佈Q2財務業績超出預期。
Haemonetics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results.
美國血液技術股價上漲,該公司發佈了高於預期的第二季度財務業績報告。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。